25 XP   0   0   10

Jw Life Science Corp
Buy, Hold or Sell?

Let's analyse Jw Life Science Corp together

PenkeI guess you are interested in Jw Life Science Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jw Life Science Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jw Life Science Corp

I send you an email if I find something interesting about Jw Life Science Corp.

Quick analysis of Jw Life Science Corp (30 sec.)










What can you expect buying and holding a share of Jw Life Science Corp? (30 sec.)

How much money do you get?

How much money do you get?
₩0.70
When do you have the money?
1 year
How often do you get paid?
81.0%

What is your share worth?

Current worth
₩10,293.65
Expected worth in 1 year
₩11,524.60
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
₩2,230.94
Return On Investment
17.9%

For what price can you sell your share?

Current Price per Share
₩12,430.00
Expected price per share
₩12,050 - ₩13,690
How sure are you?
50%

1. Valuation of Jw Life Science Corp (5 min.)




Live pricePrice per Share (EOD)

₩12,430.00

Intrinsic Value Per Share

₩-23,848.36 - ₩-29,169.14

Total Value Per Share

₩-13,554.71 - ₩-18,875.48

2. Growth of Jw Life Science Corp (5 min.)




Is Jw Life Science Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$111.5m$93.4m$10.8m10.4%

How much money is Jw Life Science Corp making?

Current yearPrevious yearGrowGrow %
Making money$4.9m$2.6m$2.3m46.8%
Net Profit Margin13.6%8.0%--

How much money comes from the company's main activities?

3. Financial Health of Jw Life Science Corp (5 min.)




What can you expect buying and holding a share of Jw Life Science Corp? (5 min.)

Welcome investor! Jw Life Science Corp's management wants to use your money to grow the business. In return you get a share of Jw Life Science Corp.

What can you expect buying and holding a share of Jw Life Science Corp?

First you should know what it really means to hold a share of Jw Life Science Corp. And how you can make/lose money.

Speculation

The Price per Share of Jw Life Science Corp is ₩12,430. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jw Life Science Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jw Life Science Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩10,293.65. Based on the TTM, the Book Value Change Per Share is ₩307.74 per quarter. Based on the YOY, the Book Value Change Per Share is ₩142.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩250.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jw Life Science Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.460.0%0.320.0%0.200.0%0.220.0%0.220.0%
Usd Book Value Change Per Share0.400.0%0.220.0%0.100.0%0.110.0%0.340.0%
Usd Dividend Per Share0.000.0%0.170.0%0.350.0%0.280.0%0.280.0%
Usd Total Gains Per Share0.400.0%0.390.0%0.450.0%0.390.0%0.630.0%
Usd Price Per Share9.01-8.96-8.86-11.63-11.81-
Price to Earnings Ratio4.85-7.80-12.60-13.11-13.38-
Price-to-Total Gains Ratio22.33-26.63-24.26-44.40-42.43-
Price to Book Ratio1.25-1.33-1.47-2.02-2.07-
Price-to-Total Gains Ratio22.33-26.63-24.26-44.40-42.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.701
Number of shares114
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.170.28
Usd Book Value Change Per Share0.220.11
Usd Total Gains Per Share0.390.39
Gains per Quarter (114 shares)44.5144.94
Gains per Year (114 shares)178.03179.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1809816812852170
2160196346256103350
3239295524384155530
4319393702512207710
5399491880640258890
647958910587683101070
755968812368963621250
8638786141410254131430
9718884159211534651610
10798982177012815171790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%20.01.00.095.2%20.01.00.095.2%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%12.08.00.060.0%13.08.00.061.9%13.08.00.061.9%
Dividend per Share2.00.02.050.0%10.00.02.083.3%16.00.04.080.0%17.00.04.081.0%17.00.04.081.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%21.00.00.0100.0%21.00.00.0100.0%

Fundamentals of Jw Life Science Corp

About Jw Life Science Corp

JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.

Fundamental data was last updated by Penke on 2024-03-25 16:38:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Jw Life Science Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jw Life Science Corp earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Jw Life Science Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 19.1% means that ₩0.19 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jw Life Science Corp:

  • The MRQ is 19.1%. The company is making a huge profit. +2
  • The TTM is 13.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.1%TTM13.6%+5.6%
TTM13.6%YOY8.0%+5.6%
TTM13.6%5Y10.2%+3.3%
5Y10.2%10Y10.3%-0.1%
1.1.2. Return on Assets

Shows how efficient Jw Life Science Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jw Life Science Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.0% Return on Assets means that Jw Life Science Corp generated ₩0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jw Life Science Corp:

  • The MRQ is 4.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM2.8%+1.2%
TTM2.8%YOY1.5%+1.2%
TTM2.8%5Y2.1%+0.7%
5Y2.1%10Y2.1%0.0%
1.1.3. Return on Equity

Shows how efficient Jw Life Science Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jw Life Science Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.4% Return on Equity means Jw Life Science Corp generated ₩0.06 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jw Life Science Corp:

  • The MRQ is 6.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ6.4%TTM4.7%+1.7%
TTM4.7%YOY2.8%+1.9%
TTM4.7%5Y3.6%+1.1%
5Y3.6%10Y3.6%0.0%

1.2. Operating Efficiency of Jw Life Science Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jw Life Science Corp is operating .

  • Measures how much profit Jw Life Science Corp makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jw Life Science Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jw Life Science Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.7%-3.7%
TTM3.7%YOY10.4%-6.7%
TTM3.7%5Y15.7%-11.9%
5Y15.7%10Y15.7%0.0%
1.2.2. Operating Ratio

Measures how efficient Jw Life Science Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.59 means that the operating costs are ₩1.59 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Jw Life Science Corp:

  • The MRQ is 1.593. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.548. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.593TTM1.548+0.045
TTM1.548YOY1.574-0.025
TTM1.5485Y1.527+0.021
5Y1.52710Y1.529-0.002

1.3. Liquidity of Jw Life Science Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jw Life Science Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.14 means the company has ₩1.14 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Jw Life Science Corp:

  • The MRQ is 1.144. The company is just able to pay all its short-term debts.
  • The TTM is 1.140. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.144TTM1.140+0.004
TTM1.140YOY1.322-0.182
TTM1.1405Y1.014+0.126
5Y1.01410Y1.003+0.011
1.3.2. Quick Ratio

Measures if Jw Life Science Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jw Life Science Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.67 means the company can pay off ₩0.67 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jw Life Science Corp:

  • The MRQ is 0.673. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.568. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.673TTM0.568+0.106
TTM0.568YOY0.694-0.126
TTM0.5685Y0.542+0.025
5Y0.54210Y0.536+0.006

1.4. Solvency of Jw Life Science Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jw Life Science Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jw Life Science Corp to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.38 means that Jw Life Science Corp assets are financed with 37.7% credit (debt) and the remaining percentage (100% - 37.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jw Life Science Corp:

  • The MRQ is 0.377. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.410. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.377TTM0.410-0.033
TTM0.410YOY0.453-0.043
TTM0.4105Y0.422-0.013
5Y0.42210Y0.424-0.002
1.4.2. Debt to Equity Ratio

Measures if Jw Life Science Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jw Life Science Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 60.5% means that company has ₩0.61 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jw Life Science Corp:

  • The MRQ is 0.605. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.700. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.605TTM0.700-0.095
TTM0.700YOY0.827-0.128
TTM0.7005Y0.737-0.037
5Y0.73710Y0.742-0.005

2. Market Valuation of Jw Life Science Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Jw Life Science Corp generates.

  • Above 15 is considered overpriced but always compare Jw Life Science Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 4.85 means the investor is paying ₩4.85 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jw Life Science Corp:

  • The EOD is 4.688. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.854. Based on the earnings, the company is cheap. +2
  • The TTM is 7.798. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.688MRQ4.854-0.166
MRQ4.854TTM7.798-2.944
TTM7.798YOY12.603-4.805
TTM7.7985Y13.113-5.315
5Y13.11310Y13.377-0.264
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jw Life Science Corp:

  • The EOD is 5.684. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.886. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 2.866. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.684MRQ5.886-0.201
MRQ5.886TTM2.866+3.020
TTM2.866YOY6.891-4.026
TTM2.8665Y25.753-22.887
5Y25.75310Y24.832+0.921
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jw Life Science Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.25 means the investor is paying ₩1.25 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Jw Life Science Corp:

  • The EOD is 1.208. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.250. Based on the equity, the company is underpriced. +1
  • The TTM is 1.332. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.208MRQ1.250-0.043
MRQ1.250TTM1.332-0.081
TTM1.332YOY1.471-0.140
TTM1.3325Y2.020-0.688
5Y2.02010Y2.071-0.052
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jw Life Science Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--576.296307.736+87%142.729+304%161.889+256%490.174+18%
Book Value Per Share--10293.6549622.931+7%8624.161+19%8441.875+22%8375.875+23%
Current Ratio--1.1441.140+0%1.322-13%1.014+13%1.003+14%
Debt To Asset Ratio--0.3770.410-8%0.453-17%0.422-11%0.424-11%
Debt To Equity Ratio--0.6050.700-14%0.827-27%0.737-18%0.742-18%
Dividend Per Share---249.999-100%499.999-100%401.222-100%406.464-100%
Eps--662.898454.386+46%291.382+128%316.261+110%315.207+110%
Free Cash Flow Per Share--546.676473.169+16%94.211+480%295.571+85%322.243+70%
Free Cash Flow To Equity Per Share--546.676-316.976+158%-54.142+110%-16.771+103%20.930+2512%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---29169.139--------
Intrinsic Value_10Y_min---23848.360--------
Intrinsic Value_1Y_max--420.974--------
Intrinsic Value_1Y_min--415.464--------
Intrinsic Value_3Y_max---1283.603--------
Intrinsic Value_3Y_min---1173.985--------
Intrinsic Value_5Y_max---6060.625--------
Intrinsic Value_5Y_min---5405.974--------
Market Cap192473578000.000-4%199286802000.000198241591500.000+1%195880190000.000+2%259489174040.000-23%263317640514.286-24%
Net Profit Margin--0.1910.136+41%0.080+141%0.102+87%0.103+86%
Operating Margin---0.037-100%0.104-100%0.157-100%0.157-100%
Operating Ratio--1.5931.548+3%1.574+1%1.527+4%1.529+4%
Pb Ratio1.208-4%1.2501.332-6%1.471-15%2.020-38%2.071-40%
Pe Ratio4.688-4%4.8547.798-38%12.603-61%13.113-63%13.377-64%
Price Per Share12430.000-4%12870.00012802.500+1%12650.000+2%16613.000-23%16867.143-24%
Price To Free Cash Flow Ratio5.684-4%5.8862.866+105%6.891-15%25.753-77%24.832-76%
Price To Total Gains Ratio21.569-4%22.33226.633-16%24.265-8%44.402-50%42.426-47%
Quick Ratio--0.6730.568+19%0.694-3%0.542+24%0.536+26%
Return On Assets--0.0400.028+45%0.015+161%0.021+94%0.021+93%
Return On Equity--0.0640.047+37%0.028+130%0.036+78%0.036+77%
Total Gains Per Share--576.296557.735+3%642.728-10%563.111+2%896.638-36%
Usd Book Value--111575185.155104305068.411+7%93479176.985+19%92184018.095+21%91436218.871+22%
Usd Book Value Change Per Share--0.4030.215+87%0.100+304%0.113+256%0.343+18%
Usd Book Value Per Share--7.2066.736+7%6.037+19%5.909+22%5.863+23%
Usd Dividend Per Share---0.175-100%0.350-100%0.281-100%0.285-100%
Usd Eps--0.4640.318+46%0.204+128%0.221+110%0.221+110%
Usd Free Cash Flow--5925538.4865128778.795+16%1021174.271+480%3232156.080+83%3519900.941+68%
Usd Free Cash Flow Per Share--0.3830.331+16%0.066+480%0.207+85%0.226+70%
Usd Free Cash Flow To Equity Per Share--0.383-0.222+158%-0.038+110%-0.012+103%0.015+2512%
Usd Market Cap134731504.600-4%139500761.400138769114.050+1%137116133.000+2%181642421.828-23%184322348.360-24%
Usd Price Per Share8.701-4%9.0098.962+1%8.855+2%11.629-23%11.807-24%
Usd Profit--7185300.7314925194.124+46%2618221.753+174%3318846.865+116%3312617.780+117%
Usd Revenue--37546208.96636200565.086+4%33062953.919+14%32223388.917+17%31993883.264+17%
Usd Total Gains Per Share--0.4030.390+3%0.450-10%0.394+2%0.628-36%
 EOD+4 -4MRQTTM+28 -7YOY+25 -105Y+27 -810Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Jw Life Science Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.688
Price to Book Ratio (EOD)Between0-11.208
Net Profit Margin (MRQ)Greater than00.191
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.673
Current Ratio (MRQ)Greater than11.144
Debt to Asset Ratio (MRQ)Less than10.377
Debt to Equity Ratio (MRQ)Less than10.605
Return on Equity (MRQ)Greater than0.150.064
Return on Assets (MRQ)Greater than0.050.040
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Jw Life Science Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.319
Ma 20Greater thanMa 5012,543.500
Ma 50Greater thanMa 10012,576.400
Ma 100Greater thanMa 20012,665.400
OpenGreater thanClose12,600.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets255,836,393
Total Liabilities96,443,271
Total Stockholder Equity159,393,122
 As reported
Total Liabilities 96,443,271
Total Stockholder Equity+ 159,393,122
Total Assets = 255,836,393

Assets

Total Assets255,836,393
Total Current Assets107,833,592
Long-term Assets148,002,801
Total Current Assets
Cash And Cash Equivalents 20,222,075
Short-term Investments 8,125,586
Net Receivables 55,322,623
Inventory 23,398,610
Other Current Assets 181,935
Total Current Assets  (as reported)107,833,592
Total Current Assets  (calculated)107,250,828
+/- 582,763
Long-term Assets
Property Plant Equipment 124,577,016
Goodwill 950,988
Intangible Assets 3,174,744
Long-term Assets Other 109,400
Long-term Assets  (as reported)148,002,801
Long-term Assets  (calculated)128,812,148
+/- 19,190,654

Liabilities & Shareholders' Equity

Total Current Liabilities94,259,092
Long-term Liabilities2,184,179
Total Stockholder Equity159,393,122
Total Current Liabilities
Short Long Term Debt 46,053,232
Accounts payable 18,739,932
Other Current Liabilities 1
Total Current Liabilities  (as reported)94,259,092
Total Current Liabilities  (calculated)64,793,165
+/- 29,465,928
Long-term Liabilities
Long term Debt 168,000
Capital Lease Obligations Min Short Term Debt91,594
Long-term Liabilities Other 53,873
Long-term Liabilities  (as reported)2,184,179
Long-term Liabilities  (calculated)313,467
+/- 1,870,712
Total Stockholder Equity
Retained Earnings 98,220,231
Total Stockholder Equity (as reported)159,393,122
Total Stockholder Equity (calculated)98,220,231
+/- 61,172,891
Other
Capital Stock39,586,385
Common Stock Shares Outstanding 15,485
Net Debt 25,999,157
Net Invested Capital 205,614,354
Net Working Capital 13,574,499
Property Plant and Equipment Gross 124,577,016



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
200,859,819
210,067,037
206,195,082
198,513,261
201,403,949
202,851,061
242,172,112
220,547,264
218,040,536
218,538,649
219,496,221
220,564,118
219,466,609
229,933,344
245,560,972
247,581,588
252,942,118
261,389,329
243,459,662
249,986,749
255,836,393
255,836,393249,986,749243,459,662261,389,329252,942,118247,581,588245,560,972229,933,344219,466,609220,564,118219,496,221218,538,649218,040,536220,547,264242,172,112202,851,061201,403,949198,513,261206,195,082210,067,037200,859,819
   > Total Current Assets 
57,926,150
68,064,354
64,424,859
57,133,880
59,855,690
62,810,119
63,525,560
82,284,981
56,496,055
56,577,124
56,020,936
59,161,526
64,430,233
78,473,293
94,194,832
96,257,085
105,008,263
114,903,089
96,900,868
104,971,867
107,833,592
107,833,592104,971,86796,900,868114,903,089105,008,26396,257,08594,194,83278,473,29364,430,23359,161,52656,020,93656,577,12456,496,05582,284,98163,525,56062,810,11959,855,69057,133,88064,424,85968,064,35457,926,150
       Cash And Cash Equivalents 
12,776,507
4,760,172
530,139
9,364,761
9,861,241
9,691,763
7,870,280
14,059,417
2,592,365
2,447,513
2,388,290
2,962,263
4,922,933
2,905,363
30,896,120
39,648,510
3,919,626
48,799,150
25,407,751
17,703,908
20,222,075
20,222,07517,703,90825,407,75148,799,1503,919,62639,648,51030,896,1202,905,3634,922,9332,962,2632,388,2902,447,5132,592,36514,059,4177,870,2809,691,7639,861,2419,364,761530,1394,760,17212,776,507
       Short-term Investments 
0
0
0
0
0
0
0
0
0
155,049
155,048
155,048
155,049
13,239,534
139,534
139,534
24,953,068
5,125,585
8,125,586
8,125,586
8,125,586
8,125,5868,125,5868,125,5865,125,58524,953,068139,534139,53413,239,534155,049155,048155,048155,049000000000
       Net Receivables 
30,353,509
46,220,285
44,993,854
136,606
34,018,954
34,376,969
35,146,815
49,704,290
36,577,634
35,513,787
34,430,236
34,469,801
37,198,398
37,493,339
40,249,622
34,262,123
53,243,927
35,754,889
38,704,845
53,596,437
55,322,623
55,322,62353,596,43738,704,84535,754,88953,243,92734,262,12340,249,62237,493,33937,198,39834,469,80134,430,23635,513,78736,577,63449,704,29035,146,81534,376,96934,018,954136,60644,993,85446,220,28530,353,509
       Inventory 
14,670,413
16,527,814
18,438,197
17,746,159
15,776,703
17,703,021
20,028,150
17,329,220
16,786,176
16,511,983
17,699,204
18,943,576
21,077,086
23,258,244
21,683,971
20,421,733
22,066,609
24,323,864
23,446,522
22,207,884
23,398,610
23,398,61022,207,88423,446,52224,323,86422,066,60920,421,73321,683,97123,258,24421,077,08618,943,57617,699,20416,511,98316,786,17617,329,22020,028,15017,703,02115,776,70317,746,15918,438,19716,527,81414,670,413
       Other Current Assets 
91,207
1
0
0
179,912
119,785
53,581
43,380
34,084
529,119
529,623
530,533
32,786
31,447
32,803
74,181
181,853
181,854
1,162,240
181,976
181,935
181,935181,9761,162,240181,854181,85374,18132,80331,44732,786530,533529,623529,11934,08443,38053,581119,785179,91200191,207
   > Long-term Assets 
0
142,002,684
141,770,223
141,379,380
141,548,260
140,040,942
178,646,552
138,262,283
161,544,482
161,961,525
163,475,285
161,402,592
155,036,376
151,460,050
151,366,140
151,324,503
147,933,855
146,486,240
146,558,794
145,014,882
148,002,801
148,002,801145,014,882146,558,794146,486,240147,933,855151,324,503151,366,140151,460,050155,036,376161,402,592163,475,285161,961,525161,544,482138,262,283178,646,552140,040,942141,548,260141,379,380141,770,223142,002,6840
       Property Plant Equipment 
132,753,436
131,944,757
131,724,790
131,434,124
131,689,696
130,240,230
128,956,134
128,770,932
135,422,674
136,624,600
138,645,163
137,434,892
137,144,814
134,653,733
135,970,758
133,728,536
131,554,784
129,322,496
127,915,707
127,156,512
124,577,016
124,577,016127,156,512127,915,707129,322,496131,554,784133,728,536135,970,758134,653,733137,144,814137,434,892138,645,163136,624,600135,422,674128,770,932128,956,134130,240,230131,689,696131,434,124131,724,790131,944,757132,753,436
       Goodwill 
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988
950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988950,988
       Long Term Investments 
500,728
500,728
504,852
506,834
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000506,834504,852500,728500,728
       Intangible Assets 
3,990,588
5,220,085
5,177,619
5,074,694
4,980,255
4,976,296
4,851,856
4,691,171
4,809,708
4,642,790
4,557,037
4,373,779
4,360,510
4,185,473
3,881,915
3,714,878
3,584,769
3,414,710
3,282,515
3,232,493
3,174,744
3,174,7443,232,4933,282,5153,414,7103,584,7693,714,8783,881,9154,185,4734,360,5104,373,7794,557,0374,642,7904,809,7084,691,1714,851,8564,976,2964,980,2555,074,6945,177,6195,220,0853,990,588
       Long-term Assets Other 
0
109,401
109,400
109,400
109,400
109,400
109,400
109,400
-347,508
-347,509
-347,508
-347,508
-28,403
-28,403
1,918
-7,057,921
109,401
-640,372
109,400
109,399
109,400
109,400109,399109,400-640,372109,401-7,057,9211,918-28,403-28,403-347,508-347,508-347,509-347,508109,400109,400109,400109,400109,400109,400109,4010
> Total Liabilities 
91,602,342
102,863,820
93,145,549
80,363,580
78,788,450
81,210,860
112,613,247
83,004,875
85,979,807
89,153,348
91,120,462
88,003,909
87,974,591
101,550,070
114,246,452
113,445,091
112,609,683
121,138,206
97,544,353
99,517,340
96,443,271
96,443,27199,517,34097,544,353121,138,206112,609,683113,445,091114,246,452101,550,07087,974,59188,003,90991,120,46289,153,34885,979,80783,004,875112,613,24781,210,86078,788,45080,363,58093,145,549102,863,82091,602,342
   > Total Current Liabilities 
73,127,257
84,707,250
76,606,112
64,641,349
66,870,913
70,140,208
62,294,585
73,715,561
69,268,190
72,204,531
74,036,169
69,848,915
83,902,304
82,519,918
65,601,758
60,551,443
80,043,501
87,770,165
94,855,381
96,789,123
94,259,092
94,259,09296,789,12394,855,38187,770,16580,043,50160,551,44365,601,75882,519,91883,902,30469,848,91574,036,16972,204,53169,268,19073,715,56162,294,58570,140,20866,870,91364,641,34976,606,11284,707,25073,127,257
       Short-term Debt 
4,999,800
37,449,800
41,019,800
38,999,800
39,039,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000039,039,80038,999,80041,019,80037,449,8004,999,800
       Short Long Term Debt 
4,999,800
37,449,800
41,019,800
38,999,800
39,039,800
33,999,800
33,999,800
43,999,800
34,816,910
36,999,220
48,785,610
47,786,000
44,686,000
37,486,000
24,686,000
24,036,000
37,016,839
38,625,286
52,597,984
53,342,944
46,053,232
46,053,23253,342,94452,597,98438,625,28637,016,83924,036,00024,686,00037,486,00044,686,00047,786,00048,785,61036,999,22034,816,91043,999,80033,999,80033,999,80039,039,80038,999,80041,019,80037,449,8004,999,800
       Accounts payable 
11,595,334
19,934,156
17,055,365
10,757,721
11,263,344
14,326,095
12,770,609
11,828,228
10,714,258
10,858,918
10,697,404
10,556,379
12,495,649
12,489,358
12,022,002
13,296,608
15,118,040
16,352,716
12,561,394
14,558,962
18,739,932
18,739,93214,558,96212,561,39416,352,71615,118,04013,296,60812,022,00212,489,35812,495,64910,556,37910,697,40410,858,91810,714,25811,828,22812,770,60914,326,09511,263,34410,757,72117,055,36519,934,15611,595,334
       Other Current Liabilities 
15,967,027
26,789,777
-1
0
15,522,872
21,123,399
13,991,366
17,328,234
22,933,734
24,040,156
13,754,617
11,031,865
25,836,190
31,994,108
27,841,940
22,476,222
0
-1
28,809,361
0
1
1028,809,361-1022,476,22227,841,94031,994,10825,836,19011,031,86513,754,61724,040,15622,933,73417,328,23413,991,36621,123,39915,522,8720-126,789,77715,967,027
   > Long-term Liabilities 
0
18,156,571
16,539,438
15,722,231
11,917,538
11,070,653
50,318,662
9,289,314
16,711,617
16,948,817
17,084,292
18,154,994
4,072,287
19,030,152
48,644,694
52,893,648
32,566,182
33,368,042
2,688,972
2,728,217
2,184,179
2,184,1792,728,2172,688,97233,368,04232,566,18252,893,64848,644,69419,030,1524,072,28718,154,99417,084,29216,948,81716,711,6179,289,31450,318,66211,070,65311,917,53815,722,23116,539,43818,156,5710
       Capital Lease Obligations 
0
280,382
455,594
347,469
237,795
212,526
397,591
272,441
208,328
126,719
350,898
281,396
191,684
135,768
279,150
251,775
171,435
194,716
179,370
218,761
91,594
91,594218,761179,370194,716171,435251,775279,150135,768191,684281,396350,898126,719208,328272,441397,591212,526237,795347,469455,594280,3820
       Long-term Liabilities Other 
0
0
-1
-1
-1
0
-1
0
0
0
0
0
0
0
0
0
93,108
93,107
93,109
53,872
53,873
53,87353,87293,10993,10793,108000000000-10-1-1-100
       Deferred Long Term Liability 
1,339,593
1,299,548
1,254,807
1,200,678
1,146,548
1,046,689
995,608
944,527
893,447
842,365
791,285
740,204
689,124
638,043
586,962
535,881
0
0
382,638
0
0
00382,63800535,881586,962638,043689,124740,204791,285842,365893,447944,527995,6081,046,6891,146,5481,200,6781,254,8071,299,5481,339,593
> Total Stockholder Equity
109,257,478
107,203,217
113,049,533
118,149,681
122,615,499
121,640,201
129,558,855
137,542,389
132,060,729
129,385,300
128,375,759
132,560,208
131,492,018
128,383,273
131,314,520
134,136,497
140,332,435
140,251,123
145,915,309
150,469,409
159,393,122
159,393,122150,469,409145,915,309140,251,123140,332,435134,136,497131,314,520128,383,273131,492,018132,560,208128,375,759129,385,300132,060,729137,542,389129,558,855121,640,201122,615,499118,149,681113,049,533107,203,217109,257,478
   Common Stock
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
39,586,385
0
0
39,586,385
0
0
0039,586,3850039,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,38539,586,385
   Retained Earnings 
41,336,063
35,898,739
41,745,055
46,845,203
54,694,084
53,718,786
61,637,440
69,620,974
64,572,462
62,016,500
63,883,399
67,822,447
70,319,127
67,210,382
70,141,629
72,963,606
79,159,544
79,078,232
84,742,418
89,296,518
98,220,231
98,220,23189,296,51884,742,41879,078,23279,159,54472,963,60670,141,62967,210,38270,319,12767,822,44763,883,39962,016,50064,572,46269,620,97461,637,44053,718,78654,694,08446,845,20341,745,05535,898,73941,336,063
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue206,860,372
Cost of Revenue-154,467,347
Gross Profit52,393,02552,393,025
 
Operating Income (+$)
Gross Profit52,393,025
Operating Expense-175,998,456
Operating Income30,861,916-123,605,432
 
Operating Expense (+$)
Research Development5,161,143
Selling General Administrative9,662,576
Selling And Marketing Expenses0
Operating Expense175,998,45614,823,719
 
Net Interest Income (+$)
Interest Income1,130,352
Interest Expense-2,693,103
Other Finance Cost-10,715
Net Interest Income-1,573,466
 
Pretax Income (+$)
Operating Income30,861,916
Net Interest Income-1,573,466
Other Non-Operating Income Expenses0
Income Before Tax (EBT)33,708,26930,861,916
EBIT - interestExpense = -2,693,103
28,143,966
30,837,069
Interest Expense2,693,103
Earnings Before Interest and Taxes (EBIT)036,401,372
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax33,708,269
Tax Provision-5,564,302
Net Income From Continuing Ops28,143,96628,143,966
Net Income28,143,966
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,573,466
 

Technical Analysis of Jw Life Science Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jw Life Science Corp. The general trend of Jw Life Science Corp is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jw Life Science Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jw Life Science Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 12,800 < 13,550 < 13,690.

The bearish price targets are: 12,360 > 12,360 > 12,050.

Tweet this
Jw Life Science Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jw Life Science Corp. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jw Life Science Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jw Life Science Corp. The current macd is -38.96132666.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jw Life Science Corp price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jw Life Science Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jw Life Science Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jw Life Science Corp Daily Moving Average Convergence/Divergence (MACD) ChartJw Life Science Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jw Life Science Corp. The current adx is 17.39.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jw Life Science Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jw Life Science Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jw Life Science Corp. The current sar is 12,800.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jw Life Science Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jw Life Science Corp. The current rsi is 41.32. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Jw Life Science Corp Daily Relative Strength Index (RSI) ChartJw Life Science Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jw Life Science Corp. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jw Life Science Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Jw Life Science Corp Daily Stochastic Oscillator ChartJw Life Science Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jw Life Science Corp. The current cci is -121.82361734.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Jw Life Science Corp Daily Commodity Channel Index (CCI) ChartJw Life Science Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jw Life Science Corp. The current cmo is -25.96445634.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jw Life Science Corp Daily Chande Momentum Oscillator (CMO) ChartJw Life Science Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jw Life Science Corp. The current willr is -75.51020408.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jw Life Science Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jw Life Science Corp Daily Williams %R ChartJw Life Science Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jw Life Science Corp.

Jw Life Science Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jw Life Science Corp. The current atr is 200.34.

Jw Life Science Corp Daily Average True Range (ATR) ChartJw Life Science Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jw Life Science Corp. The current obv is 267,290.

Jw Life Science Corp Daily On-Balance Volume (OBV) ChartJw Life Science Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jw Life Science Corp. The current mfi is 60.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jw Life Science Corp Daily Money Flow Index (MFI) ChartJw Life Science Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jw Life Science Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Jw Life Science Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jw Life Science Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.319
Ma 20Greater thanMa 5012,543.500
Ma 50Greater thanMa 10012,576.400
Ma 100Greater thanMa 20012,665.400
OpenGreater thanClose12,600.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jw Life Science Corp with someone you think should read this too:
  • Are you bullish or bearish on Jw Life Science Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jw Life Science Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jw Life Science Corp

I send you an email if I find something interesting about Jw Life Science Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Jw Life Science Corp.

Receive notifications about Jw Life Science Corp in your mailbox!